True 2 Beauty Announces Five Million Dollar Private Placement To Increase Production Capacity of "Libigrow" Family of Products

   True 2 Beauty, Inc. (PINKSHEETS: TRTB) (the "Company"), a leading manufacturer and distributor of male sexual potency pills and liquid products in the United States, announced today the "Libigrow" family of products (www.libigrow.com) will have much larger production capacity as a result of a private placement of five million dollars.

The financing is at $0.20 per share and no warrants are attached. The first $2,300,000 has been subscribed and the first wire transfer order has been received. Accredited investor customers of True 2 Beauty and European Accredited investors are the subscribers. The company expects to have the offering over subscribed.

Proceeds will be used to increase the company's Los Angeles manufacturing facility from its current one million pills per month to twenty million pills per month.

Alex Hbaiu, President and CEO of True 2 Beauty, Inc., stated, "This financing to expand our production will allow us to quickly fill our order backlog and to sign new orders from customers we met at this month's National Convenience Store Trade Show (NACS) which has 143,000 members in the United States."

About True 2 Beauty, Inc.

True 2 Beauty, Inc. is a leading manufacturer and distributor of male sexual potency pills and liquid products in the United States. The True 2 Beauty, Inc. line of current products includes Libigrow, Libigirl, Libiliquid Shots and the Libiliquid Relaxation Drink. More information on the Company and its line of products can be found at www.libigrow.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, among others, all assumptions, expectations, predictions, intentions or beliefs about future events. You are cautioned that any such forward-looking statements are not guarantees of future performance and that a number of risks and uncertainties could cause actual results of the Company to differ materially from those anticipated, expressed or implied in the forward-looking statements. The words "believe," "expect," "anticipate," "project," "targets," "optimistic," "intend," "aim," "will" or similar expressions are intended to identify forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Risks and uncertainties that could cause actual results to differ materially from those anticipated include risks related to new and existing products, product defects and any related product recall; any projections of sales, earnings, revenue, margins or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements .The Company assumes no obligation and does not intend to update any forward-looking statements, except as required by law.

For further information, please contact: Investors Relations Contact: New York World Asset Management [phone] Media Relations: Zara Hbaiu [e-mail] 1-888-942-5350